Company / Revenue per Share
Xenetic Biosciences, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$1.62
FY2025
5-year range
$0.05 / $1.65
FY2021-FY2025
Trend
-1.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2019 to $1.65 in FY2024.
Based on SEC 10-K filings.
1.62 in FY2025 with a 5-year CAGR of +256.5%.
Improved from $1.13 to $1.62 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +165.8%
- 5-Year CAGR
- +256.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share decreased 1.7% year-over-year.
- Peak revenue per share was recorded in FY2024.
- Lowest revenue per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.62 | -1.7% |
| FY2024 | $1.65 | +46.5% |
| FY2023 | $1.13 | +1203.2% |
| FY2022 | $0.09 | +72.9% |
| FY2021 | $0.05 | +1675.8% |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | -100.0% |
| FY2018 | $0.87 | +33.0% |
| FY2017 | $0.65 | - |
| FY2016 | $0.00 | -100.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026